United States Bi-Specific Antibodies Therapy Market Report & Forecast 2021-2027

Publisher Name :
Date: 09-Sep-2021
No. of pages: 92
Inquire Before Buying

United States Bi-Specific Antibodies Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Bi-Specific Antibodies Therapy Market Segment Percentages, By Type, 2020 (%)

- Fragment-Based Antibodies

- IgG-Based Antibodies

United States Bi-Specific Antibodies Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Bi-Specific Antibodies Therapy Market Segment Percentages, By Application, 2020 (%)

- Cancer

- Haemophilia

- Other Non-Cancer Diseases

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bi-Specific Antibodies Therapy revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Bi-Specific Antibodies Therapy revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Roche

- Amgen

- Sanofi

- Pfizer

- Johnson & Johnson

- AstraZeneca

- AbbVie

- Lindis Biotech

- MacroGenics, Inc

- Genmab

- Alphamab Co. Ltd

- Akeso, Inc.

United States Bi-Specific Antibodies Therapy Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Bi-Specific Antibodies Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Bi-Specific Antibodies Therapy Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Bi-Specific Antibodies Therapy Overall Market Size
2.1 United States Bi-Specific Antibodies Therapy Market Size: 2021 VS 2027
2.2 United States Bi-Specific Antibodies Therapy Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bi-Specific Antibodies Therapy Players in United States Market
3.2 Top United States Bi-Specific Antibodies Therapy Companies Ranked by Revenue
3.3 United States Bi-Specific Antibodies Therapy Revenue by Companies
3.4 Top 3 and Top 5 Bi-Specific Antibodies Therapy Companies in United States Market, by Revenue in 2020
3.5 Companies Bi-Specific Antibodies Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Players in United States Market
3.6.1 List of Tier 1 Bi-Specific Antibodies Therapy Companies in United States
3.6.2 List of Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Bi-Specific Antibodies Therapy Market Size Markets, 2021 & 2027
4.1.2 Fragment-Based Antibodies
4.1.3 IgG-Based Antibodies
4.2 By Type - United States Bi-Specific Antibodies Therapy Revenue & Forecasts
4.2.1 By Type - United States Bi-Specific Antibodies Therapy Revenue, 2016-2021
4.2.2 By Type - United States Bi-Specific Antibodies Therapy Revenue, 2022-2027
4.2.3 By Type - United States Bi-Specific Antibodies Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Bi-Specific Antibodies Therapy Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Haemophilia
5.1.4 Other Non-Cancer Diseases
5.2 By Application - United States Bi-Specific Antibodies Therapy Revenue & Forecasts
5.2.1 By Application - United States Bi-Specific Antibodies Therapy Revenue, 2016-2021
5.2.2 By Application - United States Bi-Specific Antibodies Therapy Revenue, 2022-2027
5.2.3 By Application - United States Bi-Specific Antibodies Therapy Revenue Market Share, 2016-2027
6 Bi-Specific Antibodies Therapy Companies Profiles
6.1 Roche
6.1.1 Roche Company Details
6.1.2 Roche Business Overview
6.1.3 Roche Bi-Specific Antibodies Therapy Introduction
6.1.4 Roche Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.1.5 Roche Recent Developments
6.2 Amgen
6.2.1 Amgen Company Details
6.2.2 Amgen Business Overview
6.2.3 Amgen Bi-Specific Antibodies Therapy Introduction
6.2.4 Amgen Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.2.5 Amgen Recent Developments
6.3 Sanofi
6.3.1 Sanofi Company Details
6.3.2 Sanofi Business Overview
6.3.3 Sanofi Bi-Specific Antibodies Therapy Introduction
6.3.4 Sanofi Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.3.5 Sanofi Recent Developments
6.4 Pfizer
6.4.1 Pfizer Company Details
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Bi-Specific Antibodies Therapy Introduction
6.4.4 Pfizer Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.4.5 Pfizer Recent Developments
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Details
6.5.2 Johnson & Johnson Business Overview
6.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Introduction
6.5.4 Johnson & Johnson Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.5.5 Johnson & Johnson Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Company Details
6.6.2 AstraZeneca Business Overview
6.6.3 AstraZeneca Bi-Specific Antibodies Therapy Introduction
6.6.4 AstraZeneca Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.6.5 AstraZeneca Recent Developments
6.7 AbbVie
6.7.1 AbbVie Company Details
6.7.2 AbbVie Business Overview
6.7.3 AbbVie Bi-Specific Antibodies Therapy Introduction
6.7.4 AbbVie Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.7.5 AbbVie Recent Developments
6.8 Lindis Biotech
6.8.1 Lindis Biotech Company Details
6.8.2 Lindis Biotech Business Overview
6.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Introduction
6.8.4 Lindis Biotech Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.8.5 Lindis Biotech Recent Developments
6.9 MacroGenics, Inc
6.9.1 MacroGenics, Inc Company Details
6.9.2 MacroGenics, Inc Business Overview
6.9.3 MacroGenics, Inc Bi-Specific Antibodies Therapy Introduction
6.9.4 MacroGenics, Inc Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.9.5 MacroGenics, Inc Recent Developments
6.10 Genmab
6.10.1 Genmab Company Details
6.10.2 Genmab Business Overview
6.10.3 Genmab Bi-Specific Antibodies Therapy Introduction
6.10.4 Genmab Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.10.5 Genmab Recent Developments
6.11 Alphamab Co. Ltd
6.11.1 Alphamab Co. Ltd Company Details
6.11.2 Alphamab Co. Ltd Business Overview
6.11.3 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Introduction
6.11.4 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.11.5 Alphamab Co. Ltd Recent Developments
6.12 Akeso, Inc.
6.12.1 Akeso, Inc. Company Details
6.12.2 Akeso, Inc. Business Overview
6.12.3 Akeso, Inc. Bi-Specific Antibodies Therapy Introduction
6.12.4 Akeso, Inc. Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021)
6.12.5 Akeso, Inc. Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Bi-Specific Antibodies Therapy Market Opportunities & Trends in United States Market
Table 2. Bi-Specific Antibodies Therapy Market Drivers in United States Market
Table 3. Bi-Specific Antibodies Therapy Market Restraints in United States Market
Table 4. Key Players of Bi-Specific Antibodies Therapy in United States Market
Table 5. Top Bi-Specific Antibodies Therapy Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Bi-Specific Antibodies Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Bi-Specific Antibodies Therapy Revenue Share by Companies, 2016-2021
Table 8. Companies Bi-Specific Antibodies Therapy Product Type
Table 9. List of Tier 1 Bi-Specific Antibodies Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Bi-Specific Antibodies Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Bi-Specific Antibodies Therapy Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Bi-Specific Antibodies Therapy Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Bi-Specific Antibodies Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Bi-Specific Antibodies Therapy Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Bi-Specific Antibodies Therapy Revenue (US$, Mn), 2022-2027
Table 17. Roche Company Details
Table 18. Roche Business Overview
Table 19. Roche Bi-Specific Antibodies Therapy Product
Table 20. Roche Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Roche Recent Developments
Table 22. Amgen Company Details
Table 23. Amgen Business Overview
Table 24. Amgen Bi-Specific Antibodies Therapy Product
Table 25. Amgen Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Amgen Recent Developments
Table 27. Sanofi Company Details
Table 28. Sanofi Business Overview
Table 29. Sanofi Bi-Specific Antibodies Therapy Product
Table 30. Sanofi Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Sanofi Recent Developments
Table 32. Pfizer Company Details
Table 33. Pfizer Business Overview
Table 34. Pfizer Bi-Specific Antibodies Therapy Product
Table 35. Pfizer Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Pfizer Recent Developments
Table 37. Johnson & Johnson Company Details
Table 38. Johnson & Johnson Business Overview
Table 39. Johnson & Johnson Bi-Specific Antibodies Therapy Product
Table 40. Johnson & Johnson Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Johnson & Johnson Recent Developments
Table 42. AstraZeneca Company Details
Table 43. AstraZeneca Business Overview
Table 44. AstraZeneca Bi-Specific Antibodies Therapy Product
Table 45. AstraZeneca Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. AstraZeneca Recent Developments
Table 47. AbbVie Company Details
Table 48. AbbVie Business Overview
Table 49. AbbVie Bi-Specific Antibodies Therapy Product
Table 50. AbbVie Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. AbbVie Recent Developments
Table 52. Lindis Biotech Company Details
Table 53. Lindis Biotech Business Overview
Table 54. Lindis Biotech Bi-Specific Antibodies Therapy Product
Table 55. Lindis Biotech Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Lindis Biotech Recent Developments
Table 57. MacroGenics, Inc Company Details
Table 58. MacroGenics, Inc Business Overview
Table 59. MacroGenics, Inc Bi-Specific Antibodies Therapy Product
Table 60. MacroGenics, Inc Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. MacroGenics, Inc Recent Developments
Table 62. Genmab Company Details
Table 63. Genmab Business Overview
Table 64. Genmab Bi-Specific Antibodies Therapy Product
Table 65. Genmab Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Genmab Recent Developments
Table 67. Alphamab Co. Ltd Company Details
Table 68. Alphamab Co. Ltd Business Overview
Table 69. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Product
Table 70. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Alphamab Co. Ltd Recent Developments
Table 72. Akeso, Inc. Company Details
Table 73. Akeso, Inc. Business Overview
Table 74. Akeso, Inc. Bi-Specific Antibodies Therapy Product
Table 75. Akeso, Inc. Bi-Specific Antibodies Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Akeso, Inc. Recent Developments
List of Figures
Figure 1. Bi-Specific Antibodies Therapy Segment by Type
Figure 2. Bi-Specific Antibodies Therapy Segment by Application
Figure 3. United States Bi-Specific Antibodies Therapy Market Overview: 2020
Figure 4. United States Bi-Specific Antibodies Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Bi-Specific Antibodies Therapy Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Bi-Specific Antibodies Therapy Revenue in 2020
Figure 7. By Type - United States Bi-Specific Antibodies Therapy Revenue Market Share, 2016-2027
Figure 8. By Application - United States Bi-Specific Antibodies Therapy Revenue Market Share, 2016-2027
Figure 9. Roche Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Amgen Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Sanofi Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Pfizer Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Johnson & Johnson Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. AstraZeneca Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. AbbVie Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Lindis Biotech Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. MacroGenics, Inc Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Genmab Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Akeso, Inc. Bi-Specific Antibodies Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs